<DOC>
	<DOC>NCT00286078</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.</brief_summary>
	<brief_title>Treatment for Migraines With an Implantable Device</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Be diagnosed with multiple migraines per month of moderate to severe intensity; Be refractory to medication; Be an appropriate candidate for the surgical procedures required for this study; Be willing and able to comply with all study related procedures; Be capable of reading and understanding patient information materials and giving written informed consent. Exclusion: Have onset of migraine after age 50; Have a significant psychiatric disorder; Have previously been treated with occipital nerve stimulation; Have had an injection of botulinum toxin in the head or neck within 6 months prior to enrollment; Have previously undergone destructive ganglionectomy affecting C2/C3 occipital and/or trigeminal distribution or have an occipital blockade or radio frequency procedure currently in effect; Have a condition currently requiring or likely to require the use of MRI or diathermy; Have an active implantable device; Have participated in any drug or device trial in the last 4 weeks or plan to participate in any other study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Headache</keyword>
	<keyword>Migraine</keyword>
	<keyword>Refractory</keyword>
	<keyword>Chronic</keyword>
	<keyword>Pain</keyword>
</DOC>